Jan 10, 2019 | Monica Heger
In The News
Genome Web | January 10, 2019
January 09, 2019
CEO Kevin Hrusovsky wows a packed audience with Quanterix' vision and progress towards transforming healthcare at the 2019 J.P. Morgan Health Conference in San Francisco.
FierceBiotech | November 19, 2018
by Conor Hale
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky
GenomeWeb | November 08, 2018
Nov 07, 2018 | Adam Bonislawski
GenomeWeb | November 07, 2018
NEW YORK (GenomeWeb) – Expedeon said today it has signed a supply and license agreement with Quanterix to provide that company non-exclusive access to its immunoassay offerings.
GenomeWeb | November 01, 2018
NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Thursday that its third quarter revenues rose 85 percent year-over-year, thanks largely to an 82 percent increase in quarterly product revenues.
Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced. Click the file below to hear the interview.